These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24433412)

  • 1. Predictors and moderators of outcomes of HIV/STD sex risk reduction interventions in substance abuse treatment programs: a pooled analysis of two randomized controlled trials.
    Crits-Christoph P; Gallop R; Sadicario JS; Markell HM; Calsyn DA; Tang W; He H; Tu X; Woody G
    Subst Abuse Treat Prev Policy; 2014 Jan; 9():3. PubMed ID: 24433412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: results of NIDA Clinical Trials Network Trial.
    Tross S; Campbell AN; Cohen LR; Calsyn D; Pavlicova M; Miele GM; Hu MC; Haynes L; Nugent N; Gan W; Hatch-Maillette M; Mandler R; McLaughlin P; El-Bassel N; Crits-Christoph P; Nunes EV
    J Acquir Immune Defic Syndr; 2008 Aug; 48(5):581-9. PubMed ID: 18645513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.
    Johnson WD; Diaz RM; Flanders WD; Goodman M; Hill AN; Holtgrave D; Malow R; McClellan WM
    Cochrane Database Syst Rev; 2008 Jul; (3):CD001230. PubMed ID: 18646068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sociodemographic and Substance Use Disorder Determinants of HIV Sexual Risk Behavior in Men and Women in Outpatient Drug Treatment in the NIDA National Drug Abuse Treatment Clinical Trials Network.
    Kidd JD; Tross S; Pavlicova M; Hu MC; Campbell ANC; Nunes EV
    Subst Use Misuse; 2017 Jun; 52(7):858-865. PubMed ID: 28426361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zero-inflated and hurdle models of count data with extra zeros: examples from an HIV-risk reduction intervention trial.
    Hu MC; Pavlicova M; Nunes EV
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):367-75. PubMed ID: 21854279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up after voluntary human immunodeficiency virus/sexually transmitted infection counseling, point-of-service testing, and referral to substance abuse treatment from the emergency department.
    Bernstein E; Heeren T; Winter M; Ashong D; Bliss C; Madico G; Ayalew B; Bernstein J
    Acad Emerg Med; 2012 Apr; 19(4):386-95. PubMed ID: 22506942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance Use, Depression and Sociodemographic Determinants of HIV Sexual Risk Behavior in Outpatient Substance Abuse Treatment Patients.
    Tross S; Feaster DJ; Thorens G; Duan R; Gomez Z; Pavlicova M; Hu MC; Kyle T; Erickson S; Spector A; Haynes L; Metsch LR
    J Addict Med; 2015; 9(6):457-63. PubMed ID: 26501786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motivational and skills training HIV/sexually transmitted infection sexual risk reduction groups for men.
    Calsyn DA; Hatch-Maillette M; Tross S; Doyle SR; Crits-Christoph P; Song YS; Harrer JM; Lalos G; Berns SB
    J Subst Abuse Treat; 2009 Sep; 37(2):138-50. PubMed ID: 19150206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief and intensive behavioral interventions to promote sexual risk reduction among STD clinic patients: results from a randomized controlled trial.
    Carey MP; Senn TE; Vanable PA; Coury-Doniger P; Urban MA
    AIDS Behav; 2010 Jun; 14(3):504-17. PubMed ID: 19590947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Couple-based HIV prevention for low-income drug users from New York City: a randomized controlled trial to reduce dual risks.
    El-Bassel N; Gilbert L; Wu E; Witte SS; Chang M; Hill J; Remien RH
    J Acquir Immune Defic Syndr; 2011 Oct; 58(2):198-206. PubMed ID: 21725249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender Differences in HIV Sexual Risk Behaviors Among Clients of Substance Use Disorder Treatment Programs in the U.S.
    Pan Y; Metsch LR; Wang W; Wang KS; Duan R; Kyle TL; Gooden LK; Feaster DJ
    Arch Sex Behav; 2017 May; 46(4):1151-1158. PubMed ID: 26892100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users.
    Meader N; Li R; Des Jarlais DC; Pilling S
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD007192. PubMed ID: 20091623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of a group-based computerized HIV/STI prevention intervention for black women who use drugs in the criminal justice system: study protocol for E-WORTH (Empowering African-American Women on the Road to Health), a Hybrid Type 1 randomized controlled trial.
    Johnson K; Gilbert L; Hunt T; Wu E; Metsch L; Goddard-Eckrich D; Richards S; Tibbetts R; Rowe JC; Wainberg ML; El-Bassel N
    Trials; 2018 Sep; 19(1):486. PubMed ID: 30201039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mujer Mas Segura (Safer Women): a combination prevention intervention to reduce sexual and injection risks among female sex workers who inject drugs.
    Vera A; Abramovitz D; Lozada R; Martinez G; Rangel MG; Staines H; Patterson TL; Strathdee SA
    BMC Public Health; 2012 Aug; 12():653. PubMed ID: 22891807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transitions in latent classes of sexual risk behavior among young injection drug users following HIV prevention intervention.
    Mackesy-Amiti ME; Ouellet LJ; Finnegan L; Hagan H; Golub E; Latka M; Wagner K; Garfein RS
    AIDS Behav; 2014 Mar; 18(3):464-72. PubMed ID: 23975477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An intervention to reduce HIV risk behavior of substance-using men who have sex with men: a two-group randomized trial with a nonrandomized third group.
    Mansergh G; Koblin BA; McKirnan DJ; Hudson SM; Flores SA; Wiegand RE; Purcell DW; Colfax GN;
    PLoS Med; 2010 Aug; 7(8):e1000329. PubMed ID: 20811491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family-Based HIV and Sexually Transmitted Infection Risk Reduction for Drug-Involved Young Offenders: 42-Month Outcomes.
    Rowe CL; Alberga L; Dakof GA; Henderson CE; Ungaro R; Liddle HA
    Fam Process; 2016 Jun; 55(2):305-20. PubMed ID: 26879671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterosexual Anal Sex Among Men and Women in Substance Abuse Treatment: Secondary Analysis of Two Gender-Specific HIV-Prevention Trials.
    Hatch-Maillette MA; Beadnell B; Campbell AN; Meade CS; Tross S; Calsyn DA
    J Sex Res; 2017 Jan; 54(1):33-41. PubMed ID: 26820608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV prevention intervention for substance users: a review of the literature.
    Elkbuli A; Polcz V; Dowd B; McKenney M; Prado G
    Subst Abuse Treat Prev Policy; 2019 Jan; 14(1):1. PubMed ID: 30606266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV Prevention in Rural Appalachian Jails: Implications for Re-entry Risk Reduction Among Women Who Use Drugs.
    Staton M; Strickland JC; Webster JM; Leukefeld C; Oser C; Pike E
    AIDS Behav; 2018 Dec; 22(12):4009-4018. PubMed ID: 29959722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.